Changing the Practice of Medicine
Popular
- CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
1.00 credit
Susana Campos, MD, MPH
Robert Coleman, MD, FACOG
Debra Richardson, MD
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Alessandra Tedeschi, MD
Chan Y. Cheah, MBBS
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
CME/CE
- CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Aditya Bardia, MD, MPH, FASCO
Clinical Practice
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Aditya Bardia, MD, MPH, FASCO
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Programs
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD